FDA

FDA Expands Moderna's RSV Vaccine Use To At-Risk Adults Aged 18–59 Amid CDC Panel Shake-Up

American Pharmacists Association Withholds Endorsement Of CDC's Revised COVID-19 Vaccine Guidance

RFK Jr. Champions 'Medical Freedom' While Curtailing Access, Say Public Health Experts

American Pharmacists Association Withholds Endorsement Of CDC's Revised COVID-19 Vaccine Guidance

RFK Jr. Champions 'Medical Freedom' While Curtailing Access, Say Public Health Experts

Psychedelics Policy Is Shifting In Washington: Here's What One Biotech CEO Sees Coming

51.2 Million Measles Cases, 159,200 Deaths: New Study Warns Of Surge In Preventable Diseases Amid Growing Vaccine Skepticism

Psychedelics Policy Is Shifting In Washington: Here's What One Biotech CEO Sees Coming

51.2 Million Measles Cases, 159,200 Deaths: New Study Warns Of Surge In Preventable Diseases Amid Growing Vaccine Skepticism

RFK Jr. Drops COVID Vaccine Recommendation For Healthy Kids, But Experts Warn Of Major Risks

FDA Approves Eton Pharma's Oral Drug For Adrenal Insufficiency In Pediatric Patients, Analyst Sees Boost In 2025 Revenue

FDA Recent News

FDA Limits Annual COVID-19 Boosters To High-Risk Americans, Demands New Trials For Healthy Adults In Policy Shift Under RFK Jr.

The U.S. Food and Drug Administration has announced significant changes to COVID-19 vaccine requirements, limiting annual booster approvals to older and high-risk Americans while implementing stricter clinical trial requirements for healthy adults.

Robert Kennedy Jr. Cheers FDA Plan To Ban Fluoride Supplements For Children, Calls Move 'Long Overdue'

U.S. Health Secretary Robert F. Kennedy Jr. praised the Food and Drug Administration's decision to begin removing fluoride supplements for children from the market, calling the move "long overdue."

Trump Orders FDA To Fast-Track US Drug Production As Tariff Threat Looms On Imported Medicines: Cites National Security Concerns

President Donald Trump signed an executive order Monday directing the FDA to accelerate approvals for domestic pharmaceutical manufacturing facilities as his administration prepares to announce new tariffs on imported medicines within two weeks

Elon Musk Says Neuralink Will 'Ultimately' Be Available To All As FDA Grants Breakthrough Status For Speech-Restoring Brain Tech

Elon Musk announced plans to make Neuralink's brain-computer interface technology "widely available" following the company's receipt of Breakthrough Device Designation from the FDA for restoring communication in severely speech-impaired individuals.

Trump-Era FDA Appointees Request New Trials For Novavax COVID Vaccine, Reportedly Delaying Approval Timeline

The President Donald Trump administration's request for Novavax Inc. to conduct new clinical trials for its COVID-19 vaccine has created uncertainty across the vaccine industry, potentially affecting other manufacturers.

Health Care Technology Stocks Surge After FDA Announces Plans To Phase Out Animal Testing Requirements

Several stocks in the health care technology space are moving higher after the market close on Thursday after the U.S. Food and Drug Administration (FDA) announced plans to phase out animal testing requirements.

Office of Minority Health Targeted as RFK Jr. Drives Deep Cuts Across CMS

The Centers for Medicare & Medicaid Services has reportedly eliminated jobs in multiple key divisions, including its Office of Minority Health.

RFK Jr. Spreading 'Misinformation and Lies'? FDA's Top Vaccine Official Walks Out, Sparking Debate on Safety and Public Trust

The FDA's top vaccine official has resigned, citing concerns over HHS Secretary Kennedy promotion of vaccine misinformation.

Acne Products At Walgreens Flagged For Benzene, Recalls Announced

FDA tested 95 benzoyl peroxide acne products for benzene, finding six with elevated levels. Affected brands issued retail-level recalls with no consumer action needed.

FDA Sets Decision Date For Glaukos' Keratoconus Treatment Without The Need Of Surgery

Glaukos' Epioxa NDA for keratoconus is under FDA review, with a decision expected by October 2025. Phase 3 trials support its non-invasive treatment potential.

DOGE Reportedly Fires FDA Staff Reviewing Elon Musk's Neuralink: 'We Should Be Worried About The Whole Trial,' Says Former Official

Several U.S. Food and Drug Administration (FDA) employees involved in the review of Tesla (NASDAQ: TSLA) Chief, Elon Musk's private brain implant company, Neuralink, were dismissed over the weekend.

FDA Approves First Non-Opioid Pain Pill, As Medical Marijuana Remains A Proven Alternative For Relief

FDA approves non-opioid pain reliever, suzetrigine, by Vertex Pharmaceuticals to mitigate risks of opioids and provide patients with more options.

Ozempic Receives FDA Approval To Treat Kidney Disease

The FDA on Tuesday approves Ozempic, the weight loss drug made by Novo Nordisk, for the treatment of chronic kidney disease in patients who also have type 2 diabetes.

Sanofi Genzyme Facility Draws FDA Criticism Over Alleged Quality Lapses

FDA issues warning letter to Sanofi over its Genzyme facility, citing process deviations, equipment issues, and quality oversight lapses.

FDA Bans Red Dye No. 3 Effective January 2027, Cites Cancer Risks: Food Stocks To Watch

The U.S. Food and Drug Administration announced a ban on Red No. 3, an artificial food coloring linked to cancer in animal studies, effective Jan. 15, 2027.

Eli Lilly's Zepbound Receives FDA Approval For Obesity-Linked Sleep Apnea Drug

The FDA approved Eli Lilly's Zepbound as the first drug for obesity-linked moderate-to-severe sleep apnea, potentially transforming treatment options for 80 million Americans.

Supreme Court Hears Case Against FDA Ban On Flavored Vapes: Here Are The Stocks To Watch

A Supreme Court ruling on a case against the FDA could change the e-cigarette and vaping market.

Pharma-Grade Cannabis Could Hit Walgreens & CVS—But Can The Industry Survive The FDA?

As the formal review process for rescheduling cannabis unfolds, industry players are closely watching its potential to transform the sector.

Kennedy's War On Food Dyes Could Be Coming To Your Breakfast Table

Robert F. Kennedy Jr. is a vocal opponent of artificial food dyes, blaming them in part for the "chronic disease epidemic" in America. He may get the opportunity to bring major changes to the U.S. food industry under the incoming Trump administration.

FDA Approves Cannabis Trial For Veterans With PTSD After Years Of Delays

FDA approves Phase 2 cannabis trial for veterans with PTSD, funded by Michigan marijuana taxes. Study to assess smoked cannabis efficacy.

FDA Endorses CaaMTech's Psilocin Drug Development For Depression Treatment

FDA supports CaaMTech's CT-4201 psilocin program for depression, advancing psychedelic therapy and clearing key regulatory hurdles.

Trump's Potential 'Health Czar' Robert F. Kennedy Jr. Rattles Vaccine Stocks: 'Shoot First Reaction'

Donald Trump has said he will give Robert F. Kennedy Jr. a senior role in his incoming administration to advance his "Make America Healthy Again" agenda.

Trump Has Asked Me To Do 3 Things, Says Robert Kennedy Jr.

Robert Kennedy Jr. revealed Trump's directive to tackle health agency corruption, promote science, and end chronic disease.